Omeza, LLC

Omeza is a regenerative skincare and wound care company specializing in marine-based therapies for chronic and hard-to-heal wounds. Founded in 2017 and headquartered in Sarasota, Florida, the company develops proprietary Omega-3 and OCM™ (Omeza Collagen Matrix) technology to enhance skin integrity and optimize wound healing outcomes. OCM™ is an FDA-cleared, drug-device combination therapy designed to address all phases of wound healing, from acute trauma and diabetic foot ulcers to venous leg ulcers and other chronic wounds. Omeza's product portfolio includes the Omeza® Collagen Matrix Rx, Omeza® Skin Protectant, and Omeza® Lidocaine Lavage, all formulated to reduce biofilm, promote epithelialization, and prevent hospital admissions or amputations. The company distributes nationally through healthcare partnerships and received recognition as a Top Innovation in Wound Care 2022.